Literature DB >> 20403346

ACE inhibitor use was associated with lower serum dehydroepiandrosterone concentrations in older men.

T Kwok1, C Ohlsson, L Vandenput, N Tang, Y F Zhang, B Tomlinson, P C Leung.   

Abstract

CONTEXT: Angiotensin converting enzyme (ACE) activity may influence the production of adrenal androgen precursors and testosterone. Use of ACE inhibitors may therefore have an influence on serum sex hormone concentrations in older men. DESIGN AND METHODS: 1486 out of 2,000 community-dwelling Chinese men aged 65years who participated in a cohort study were randomly selected to have archived fasting morning serum analyzed for androgen precursors and sex hormones. DNA was extracted from whole blood and analyzed for ACE gene I/D polymorphism.
RESULTS: Subjects with the ACE gene D allele (higher ACE activity) had higher serum dehydroepiandrosterone (DHEA) sulphate and DHEA than those with I/I genotype (P=0.014 and 0.018 respectively, Mann Whitney test). These differences were not significant after Bonferroni correction. Among those with history of hypertension, but without diabetes mellitus or cardiac failure, users of ACE inhibitors had significantly lower serum DHEA (median 1.78 versus 1.49ng/ml in non-users, P=0.0074, Mann Whitney test) and also tended to have lower serum androstenedione and androst-5-ene-3beta,17beta-diol (0.68 versus 0.72ng/ml in non-users; 552.4 versus 624.1pg/ml respectively, both P values <0.05). Serum testosterone and estradiol were not significantly changed.
CONCLUSIONS: ACE inhibitor use was associated with lower serum DHEA in older men. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20403346      PMCID: PMC2883618          DOI: 10.1016/j.cca.2010.04.011

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  29 in total

1.  Effects of ramipril on the hormone concentrations in serum of hypertensive patients.

Authors:  P E Grönroos; K M Irjala; R K Vesalainen; I M Kantola; V M Leinonen; T I Helenius; J J Forsström
Journal:  Eur J Clin Chem Clin Biochem       Date:  1997-06

2.  Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.

Authors:  F Labrie; A Bélanger; L Cusan; J L Gomez; B Candas
Journal:  J Clin Endocrinol Metab       Date:  1997-08       Impact factor: 5.958

3.  The Physical Activity Scale for the Elderly (PASE): development and evaluation.

Authors:  R A Washburn; K W Smith; A M Jette; C A Janney
Journal:  J Clin Epidemiol       Date:  1993-02       Impact factor: 6.437

4.  Comparative rates of androgen production and metabolism in Caucasian and Chinese subjects.

Authors:  S J Santner; B Albertson; G Y Zhang; G H Zhang; M Santulli; C Wang; L M Demers; C Shackleton; R J Santen
Journal:  J Clin Endocrinol Metab       Date:  1998-06       Impact factor: 5.958

5.  Lisinopril decreases plasma free testosterone in male hypertensive patients and increases sex hormone binding globulin in female hypertensive patients.

Authors:  H Koshida; R Takeda; I Miyamori
Journal:  Hypertens Res       Date:  1998-12       Impact factor: 3.872

6.  Effect of angiotensin II on secretion of adrenal androgens.

Authors:  T Yanase; T Maki; H Nawata; K Kato; H Ibayashi
Journal:  Endocrinol Jpn       Date:  1984-12

7.  Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes.

Authors:  O Costerousse; J Allegrini; M Lopez; F Alhenc-Gelas
Journal:  Biochem J       Date:  1993-02-15       Impact factor: 3.857

8.  Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism.

Authors:  A H Danser; M A Schalekamp; W A Bax; A M van den Brink; P R Saxena; G A Riegger; H Schunkert
Journal:  Circulation       Date:  1995-09-15       Impact factor: 29.690

9.  A possible role for the brain renin-angiotensin system in the regulation of LH secretion.

Authors:  M K Steele; R V Gallo; W F Ganong
Journal:  Am J Physiol       Date:  1983-12

10.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

Authors:  B Rigat; C Hubert; F Alhenc-Gelas; F Cambien; P Corvol; F Soubrier
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

View more
  4 in total

1.  Does the use of ACE inhibitors or angiotensin receptor blockers affect bone loss in older men?

Authors:  T Kwok; J Leung; Y F Zhang; D Bauer; K E Ensrud; E Barrett-Connor; P C Leung
Journal:  Osteoporos Int       Date:  2011-11-12       Impact factor: 4.507

2.  The effect of angiotensin-converting enzyme inhibitor use on bone loss in elderly Chinese.

Authors:  Ya-Feng Zhang; Ling Qin; Ping-Chung Leung; Timothy C Y Kwok
Journal:  J Bone Miner Metab       Date:  2012-06-29       Impact factor: 2.626

3.  Does angiotensin-converting enzyme polymorphism have association with symptomatic benign prostatic hyperplasia?

Authors:  Hemant Kumar Bid; Parmeet Kaur Manchanda; Rituraj Konwar; Kasif Hanif; V Laxman Nayak; Vishwajeet Singh
Journal:  Indian J Urol       Date:  2010-10

4.  Angiotensin System Inhibitors May Improve Outcomes of Patients With Castration-Resistant Prostate Cancer During Abiraterone Acetate Treatment-A Cardio-Oncology Study.

Authors:  Michał Wilk; Anna Waśko-Grabowska; Iwona Skoneczna; Sebastian Szmit
Journal:  Front Oncol       Date:  2021-04-01       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.